Innovative
Better methods, adopted with care.
Risk-based monitoring, electronic data capture and decentralized options, used where they make a trial safer, faster or easier to join.
Contract research organization · Philippines
Evidence, brought to light.
Sinag Clinical Research helps pharmaceutical, biotech and medical device sponsors run Phase I to IV clinical trials in the Philippines, with the scientific rigor, regulatory precision and care for participants that trustworthy evidence depends on.
si·nag Filipino, noun. A ray of light; radiance.
- Phase I Safety and dosage 20–100 participants
- Phase II Efficacy and side effects Up to several hundred
- Phase III Efficacy and adverse reactions 300–3,000 participants
- Phase IV Safety after approval Several thousand
Four principles behind every study
Research
Science sets the agenda.
Sound protocols, fit-for-purpose endpoints, and statistics planned before the first participant is enrolled.
Reliable
Quality built in from day one.
ICH E6(R3) Good Clinical Practice, ALCOA+ data integrity, and timelines we can stand behind.
Clinical
Participants come first.
Safety, informed consent and dignity guide every decision, from site selection to the final visit.
Services
Full-service clinical research, from feasibility to final report.
Engage us for a complete study or for the parts you need. Either way, one team stays accountable for quality and timelines.
-
Feasibility and site selection
Evidence-based feasibility, investigator identification and site qualification, so enrollment targets are realistic from the start.
Country feasibility · Site qualification · Enrollment modeling
-
Regulatory and ethics submissions
Clinical trial applications to the Philippine FDA, ethics committee submissions and import licenses for investigational products, managed end to end.
FDA CTA · Ethics review · Import license
-
Project management
One accountable team for timelines, budgets, vendors and risk, with clear reporting from start-up to close-out.
Timelines · Budgets · Vendor oversight
-
Clinical monitoring
Risk-based, on-site and remote monitoring by GCP-trained clinical research associates, focused on participant safety and data quality.
RBQM · Source data review · Remote monitoring
-
Data management and biostatistics
EDC builds, data cleaning, statistical analysis plans and analyses designed to produce regulatory-grade evidence.
EDC · SAP · CDISC
-
Safety and medical writing
Adverse event processing and expedited safety reporting, plus protocols, reports and submissions written with clarity.
SAE reporting · DSUR · Clinical study reports
How we work
From protocol to proof.
Every study moves through the same four stages, with the same team from the first feasibility call to the archived trial master file.
-
Stage 01
Feasibility
Protocol review, country and site feasibility, patient population insight and a realistic budget.
-
Stage 02
Start-up
Philippine FDA clinical trial application, ethics committee approval, import license, site contracts and activation.
-
Stage 03
Conduct
Enrollment support, risk-based monitoring, data management and safety reporting, with status updates you can act on.
-
Stage 04
Close-out
Database lock, site close-out, statistical analysis, the clinical study report and an inspection-ready trial master file.
Why the Philippines
A strong place for your next trial.
The Philippines combines a large, diverse population with an established regulatory pathway. We help sponsors use those strengths well.
- Diverse patient populations
- More than 110 million people and a broad disease burden, including many patients who have not yet received treatment.
- English as a working language
- Medicine and research are taught and practiced in English, which simplifies documents, training and communication with global teams.
- A defined regulatory pathway
- Trials are authorized by the Philippine FDA and reviewed by ethics committees accredited by the Philippine Health Research Ethics Board.
- Cost-efficient delivery
- Competitive operating costs within Asia-Pacific, with no compromise on Good Clinical Practice.
About Sinag
Our mission
We help pharmaceutical, biotech and medical device partners bring safe, effective therapies to patients sooner, by running clinical trials with scientific rigor, regulatory precision and genuine care for every participant.
Our vision
To be Southeast Asia’s most trusted clinical research partner, bringing better medicines to light through innovative science, reliable data and ethical care.
Sinag is Filipino for “ray of light.” Our colors follow light into deep water: teal for the depth of the science, cyan for the clarity of the result.
Contact
Planning a study? Let’s talk.
Tell us about your protocol, timelines and target population. We’ll reply with an initial feasibility view and a clear next step.
Based in
The Philippines, working with sponsors across Asia-Pacific.
Email us about your study